ArticleJournal of the Chinese Medical Association : JCMA2024

Survival outcomes of radium-223 therapy for metastatic castration-resistant prostate cancer following national health insurance reimbursement in Taiwan.

Shan-Fan Yao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.